![]() ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members. Disclaimer ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||
One In Three Patients Develop Fibromyalgia After A Surgical Mesh Implant, Warns Patient Support GroupThursday 7 September 2017
From UK news outlet the Wisbech Standard:
One in three patients develop fibromyalgia after a surgical mesh implant, warns patient support group One in three people who have had a surgical mesh implant to treat incontinence, prolapse or hernia go on to develop fibromyalgia according to a patient survey. Sling The Mesh support group ran a poll which revealed that 54 out of 187 people developed diagnosed fibromyalgia following a polypropylene plastic implant - 29 per cent. The number suffering fibromyalgia in the general population is 4.7 per cent according to a UK charity which this week runs an awareness campaign into the painful condition. A study in the BMJ shows the number suffering in the general population is 5.4 per cent. A Sling The Mesh spokesman said: “Our survey shows the incidence of fibromyalgia in mesh patients is around six times higher than what you would expect in the general population.”
blog comments powered by Disqus |
||||||||||||
|
Registered Charity 3104
Email:
sacfs@sacfs.asn.au
Mailing address:
PO Box 322,
Modbury North,
South Australia 5092
Phone:
1300 128 339
Office Hours:
Monday - Friday,
10am - 4pm
(phone)